FDA Inspection 1314762 — Brian C. DeBeaubien, M.D.

Brian C. DeBeaubien, M.D. — FEI 3043365433

The FDA completed an inspection of Brian C. DeBeaubien, M.D. on April 24, 2026 in Saginaw, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 24, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Saginaw, MI (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance